Kimberly Pope
Human Resources Officer bij ADC THERAPEUTICS SA
Vermogen: 935 824 $ op 31-03-2024
Profiel
Kimberly Pope is currently the Chief People Officer at ADC Therapeutics SA. Prior to this, she held positions as the Director of Human Resources at Hospira, Inc. and Global Marketing & Development Solutions.
She also served as the Group Vice President of Human Resources at IDEX Corp.
from 2013 to 2016.
From 2016 to 2020, she was the Senior Vice President of Human Resources at Array BioPharma, Inc. Ms. Pope obtained her undergraduate degree from the University of Iowa and also studied at the Tippie College of Business.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ADC THERAPEUTICS LTD
0.25% | 01-02-2023 | 208 424 ( 0.25% ) | 935 824 $ | 31-03-2024 |
Actieve functies van Kimberly Pope
| Bedrijven | Functie | Begin |
|---|---|---|
| ADC THERAPEUTICS SA | Human Resources Officer | 17-08-2020 |
Eerdere bekende functies van Kimberly Pope
| Bedrijven | Functie | Einde |
|---|---|---|
| ARRAY TECHNOLOGIES, INC. | Human Resources Officer | 01-01-2019 |
| IDEX CORPORATION | Human Resources Officer | 01-01-2016 |
| Global Marketing & Development Solutions | Human Resources Officer | - |
| HOSPIRA, INC. | Human Resources Officer | - |
Opleiding van Kimberly Pope
| University of Iowa | Undergraduate Degree |
| Tippie College of Business | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| IDEX CORPORATION | Producer Manufacturing |
| ADC THERAPEUTICS SA | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Array BioPharma, Inc.
 Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Array BioPharma, Inc. is a biopharmaceutical company. Its focus is on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and other high-burden diseases. The company's products are BRAFTOVI and MEKTOVI. Its portfolio includes Binimetinib, Selumetinib, Encorafenib, Filanesib, Ipatasertib, Varltinib, Danoprevir, ARRY-797, Larotrectinib, Tucatinib, ARRY-382, Motolimod, Prexasertib, GDC-0575, LOXO-292, LOXO-195, and AK-1830. The company was founded by Kevin Koch, Anthony D. Piscopio, K. C. Nicolaou, and David L. Snitman in 1998 and is headquartered in Boulder, CO. | Health Technology |
Hospira, Inc.
 Hospira, Inc. Pharmaceuticals: MajorHealth Technology Hospira, Inc. provides injectable drugs and infusion technologies. It offers drugs, IV sets and clinical integration, infusion pumps, clinical software and implementation services. The company was founded on September 16, 2003 and is headquartered in Lake Forest, IL. | Health Technology |
| Global Marketing & Development Solutions |
